Geron (GERN -4.3%) looks like it will be unable to use its imetelstat drug for treating...

|About: Geron Corporation (GERN)|By:, SA News Editor

Geron (GERN -4.3%) looks like it will be unable to use its imetelstat drug for treating lung-cancer patients after final results from a Phase II study confirm that the medicine was ineffective in a sub-group of patients in which initial results had looked promising. (PR)